Literature DB >> 15609015

[Liver tumor ablation].

Th Helmberger1, R-Th Hoffmann, T Jakobs, Th Leibecke, A Lubienski, M Reiser.   

Abstract

Minimal-invasive techniques for ablation of primary and secondary hepatic tumors gain increasingly clinical importance. This is especially true since surgical resection and classic chemotherapy is successful only in a limited number of patients. Local ablative methods incorporate chemo- (percutaneous alcohol instillation, transarterial chemoembolization), thermo- (radiofrequency-, laser-, microwave-, cryoablation, high intensive focused ultrasound) and radio-ablative techniques (interstitial brachytherapy, selective internal radiotherapy). Regarding their implementation and specific effects these methods are varying widely, nevertheless all of them have a high therapeutical efficacy together with a low complication rate in common-correct application presumed. The knowledge on specific indications and contraindications is crucial to implement these methods into multimodality therapy concepts.

Entities:  

Mesh:

Year:  2005        PMID: 15609015     DOI: 10.1007/s00117-004-1149-y

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  34 in total

1.  Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver.

Authors:  J Bruix; M Sherman; J M Llovet; M Beaugrand; R Lencioni; A K Burroughs; E Christensen; L Pagliaro; M Colombo; J Rodés
Journal:  J Hepatol       Date:  2001-09       Impact factor: 25.083

2.  Radio-frequency ablation of colorectal liver metastases in 167 patients.

Authors:  A R Gillams; W R Lees
Journal:  Eur Radiol       Date:  2004-07-27       Impact factor: 5.315

Review 3.  Hepatocellular carcinoma: current management and future trends.

Authors:  Brian I Carr
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

4.  Liver malignancies: CT-guided interstitial brachytherapy in patients with unfavorable lesions for thermal ablation.

Authors:  Jens Ricke; Peter Wust; Gero Wieners; Alexander Beck; Chie Hee Cho; Max Seidensticker; Maciej Pech; Michael Werk; Christian Rosner; Enrique Lopez Hänninen; Torsten Freund; Roland Felix
Journal:  J Vasc Interv Radiol       Date:  2004-11       Impact factor: 3.464

5.  Microwave coagulation therapy for unresectable hepatocellular carcinoma.

Authors:  Masanori Aramaki; Katsunori Kawano; Tsuyoshi Ohno; Atsushi Sasaki; Koichiro Tahara; Seiichiro Kai; Yukio Iwashita; Seigo Kitano
Journal:  Hepatogastroenterology       Date:  2004 Nov-Dec

6.  Randomised phase 2 trial of SIR-Spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer.

Authors:  Guy Van Hazel; Anthony Blackwell; James Anderson; David Price; Paul Moroz; Geoff Bower; Giuseppe Cardaci; Bruce Gray
Journal:  J Surg Oncol       Date:  2004-11-01       Impact factor: 3.454

Review 7.  The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma.

Authors:  Josep M Llovet; Josep Fuster; Jordi Bruix
Journal:  Liver Transpl       Date:  2004-02       Impact factor: 5.799

8.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.

Authors:  Herbert Hurwitz; Louis Fehrenbacher; William Novotny; Thomas Cartwright; John Hainsworth; William Heim; Jordan Berlin; Ari Baron; Susan Griffing; Eric Holmgren; Napoleone Ferrara; Gwen Fyfe; Beth Rogers; Robert Ross; Fairooz Kabbinavar
Journal:  N Engl J Med       Date:  2004-06-03       Impact factor: 91.245

9.  Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection.

Authors:  Riccardo A Lencioni; Hans-Peter Allgaier; Dania Cioni; Manfred Olschewski; Peter Deibert; Laura Crocetti; Holger Frings; Joerg Laubenberger; Ina Zuber; Hubert E Blum; Carlo Bartolozzi
Journal:  Radiology       Date:  2003-05-20       Impact factor: 11.105

10.  [CT-guided interstitial brachytherapy of lung malignancies. Technique and first results].

Authors:  J Ricke; P Wust; S Hengst; G Wieners; M Pech; H Herzog; R Felix
Journal:  Radiologe       Date:  2004-07       Impact factor: 0.635

View more
  2 in total

1.  [Metastases of colorectal carcinoma].

Authors:  S Clasen; H Rempp; P L Pereira
Journal:  Radiologe       Date:  2008-11       Impact factor: 0.635

Review 2.  [Combined therapies including interventional radiology].

Authors:  S Clasen; P L Pereira
Journal:  Radiologe       Date:  2007-12       Impact factor: 0.803

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.